Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies

August 1, 2001
Shabbir T. Anik, PhD

Shabbir T. Anik, PhD, is vice­president of scientific affairs and global PDS operations, Patheon, Inc., 2100 Syntex Court, Mississauga, ON, Canada L5N 7K9, tel. 650.962.8406.

Colin M. Minchom, PhD

Colin M. Minchom, PhD, is group director of PDS operations, Toronto region operations at Patheon, Inc.

Pharmaceutical Technology, Pharmaceutical Technology-08-01-2001, Volume 2001 Supplement, Issue 2

Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.